ArticleScientific reports2025

Feasibility of de-escalating axillary surgery in patients with clinical N2-3, pathological N0 breast cancer after neoadjuvant chemotherapy.

Ee Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.